Home / Energy Alternative Sources / Dyskinesia Global Clinical Trials Review, H1, 2015

Dyskinesia Global Clinical Trials Review, H1, 2015

Published: Feb 2015 | No Of Pages: 100 | Published By: GlobalData

Dyskinesia Global Clinical Trials Review, H1, 2015

Summary

GlobalData's clinical trial report, “Dyskinesia Global Clinical Trials Review, H1, 2015" provides data on the Dyskinesia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Dyskinesia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Dyskinesia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Dyskinesia 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Dyskinesia to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Dyskinesia to Central Nervous System Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Dyskinesia 25
Subjects Recruited Over a Period of Time 29
Clinical Trials by Sponsor Type 30
Prominent Sponsors 31
Top Companies Participating in Dyskinesia Therapeutics Clinical Trials 32
Prominent Drugs 33
Latest Clinical Trials News on Dyskinesia 34
Feb 09, 2015: Adamas Pharmaceuticals' Phase 2/3 Clinical Study Published in Movement Disorders 34
Clinical Trial Profiles 35
Clinical Trial Overview of Top Companies 35
Ipsen S.A. 35
Clinical Trial Overview of Ipsen S.A. 35
Neurocrine Biosciences, Inc. 37
Clinical Trial Overview of Neurocrine Biosciences, Inc. 37
Allergan, Inc. 38
Clinical Trial Overview of Allergan, Inc. 38
Merz Pharma GmbH & Co. KgaA 39
Clinical Trial Overview of Merz Pharma GmbH & Co. KgaA 39
Novartis AG 40
Clinical Trial Overview of Novartis AG 40
Auspex Pharmaceuticals, Inc. 41
Clinical Trial Overview of Auspex Pharmaceuticals, Inc. 41
UCB S.A. 42
Clinical Trial Overview of UCB S.A. 42
Eisai Co., Ltd. 43
Clinical Trial Overview of Eisai Co., Ltd. 43
E. Merck KG 44
Clinical Trial Overview of E. Merck KG 44
Adamas Pharmaceuticals, Inc. 45
Clinical Trial Overview of Adamas Pharmaceuticals, Inc. 45
Clinical Trial Overview of Top Institutes / Government 46
National Institute of Neurological Disorders and Stroke 46
Clinical Trial Overview of National Institute of Neurological Disorders and Stroke 46
University Health Network 47
Clinical Trial Overview of University Health Network 47
University of Florida 48
Clinical Trial Overview of University of Florida 48
Oregon Health & Science University 49
Clinical Trial Overview of Oregon Health & Science University 49
Leiden University Medical Center 50
Clinical Trial Overview of Leiden University Medical Center 50
Rush University Medical Center 51
Clinical Trial Overview of Rush University Medical Center 51
Seoul National University Hospital 52
Clinical Trial Overview of Seoul National University Hospital 52
Taoyuan Mental Hospital 53
Clinical Trial Overview of Taoyuan Mental Hospital 53
University of Iowa 54
Clinical Trial Overview of University of Iowa 54
Vanderbilt University 55
Clinical Trial Overview of Vanderbilt University 55
Five Key Clinical Profiles 56
Appendix 98
Abbreviations 98
Definitions 98
Research Methodology 99
Secondary Research 99
About GlobalData 100
Contact Us 100
Disclaimer 100
Source 100

List of Tables
Dyskinesia Therapeutics, Global, Clinical Trials by Region, 2015* 7
Dyskinesia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Dyskinesia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Dyskinesia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Dyskinesia Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Dyskinesia Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Dyskinesia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015* 13
Dyskinesia Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14
Proportion of Dyskinesia to Central Nervous System Clinical Trials, G7 Countries (%), 2015* 15
Dyskinesia Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Dyskinesia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Dyskinesia to Central Nervous System Clinical Trials, E7 Countries (%), 2015* 18
Dyskinesia Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Dyskinesia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Dyskinesia Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Dyskinesia Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Dyskinesia Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Dyskinesia Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Dyskinesia Therapeutics, Global, Suspended Clinical Trials, 2015* 25
Dyskinesia Therapeutics, Global, Withdrawn Clinical Trials, 2015* 26
Dyskinesia Therapeutics, Global, Terminated Clinical Trials, 2015* 27
Dyskinesia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 29
Dyskinesia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 30
Dyskinesia Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 31
Dyskinesia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 32
Dyskinesia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 33
Dyskinesia Therapeutics Clinical Trials Market, Global, Clinical Trials by Ipsen S.A., 2015* 35
Dyskinesia Therapeutics Clinical Trials Market, Global, Clinical Trials by Neurocrine Biosciences, Inc., 2015* 37
Dyskinesia Therapeutics Clinical Trials Market, Global, Clinical Trials by Allergan, Inc., 2015* 38
Dyskinesia Therapeutics Clinical Trials Market, Global, Clinical Trials by Merz Pharma GmbH & Co. KgaA, 2015* 39
Dyskinesia Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 40
Dyskinesia Therapeutics Clinical Trials Market, Global, Clinical Trials by Auspex Pharmaceuticals, Inc., 2015* 41
Dyskinesia Therapeutics Clinical Trials Market, Global, Clinical Trials by UCB S.A., 2015* 42
Dyskinesia Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Co., Ltd., 2015* 43
Dyskinesia Therapeutics Clinical Trials Market, Global, Clinical Trials by E. Merck KG, 2015* 44
Dyskinesia Therapeutics Clinical Trials Market, Global, Clinical Trials by Adamas Pharmaceuticals, Inc., 2015* 45
Dyskinesia Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Neurological Disorders and Stroke, 2015* 46
Dyskinesia Therapeutics Clinical Trials Market, Global, Clinical Trials by University Health Network, 2015* 47
Dyskinesia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Florida, 2015* 48
Dyskinesia Therapeutics Clinical Trials Market, Global, Clinical Trials by Oregon Health & Science University, 2015* 49
Dyskinesia Therapeutics Clinical Trials Market, Global, Clinical Trials by Leiden University Medical Center, 2015* 50
Dyskinesia Therapeutics Clinical Trials Market, Global, Clinical Trials by Rush University Medical Center, 2015* 51
Dyskinesia Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2015* 52
Dyskinesia Therapeutics Clinical Trials Market, Global, Clinical Trials by Taoyuan Mental Hospital, 2015* 53
Dyskinesia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Iowa, 2015* 54
Dyskinesia Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt University, 2015* 55

List of Figures
Dyskinesia Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Dyskinesia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Dyskinesia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Dyskinesia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Dyskinesia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Dyskinesia Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Dyskinesia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015* 13
Dyskinesia Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015* 14
Proportion of Dyskinesia to Central Nervous System Clinical Trials, G7 Countries (%), 2015* 15
Dyskinesia Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Dyskinesia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Dyskinesia to Central Nervous System Clinical Trials, E7 Countries (%), 2015* 18
Dyskinesia Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Dyskinesia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Dyskinesia Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Dyskinesia Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Dyskinesia Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Dyskinesia Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Dyskinesia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 29
Dyskinesia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 30
Dyskinesia Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 31
Dyskinesia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 32
Dyskinesia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 33
GlobalData Methodology 99

Choose License Type
 
Contact Information
24/7 Research Support
Phone: +1-855-455-8662
sales@acutemarketreports.com
Get in Touch with us
join us on Facebook
Follow us on Twitter
Follow us on LinkedIn
Add us on Google +